HomeNews by TopicNews by CountryEditor's Picks Advertise All Services About EIN

Schering News

Pharmaceutical Companies

> Schering

FORMATS: RSS | EMAIL | MOBILE

Latest Schering News

MEDRAD Sponsors PET Research with University of Zurich 6 Jan 2009 18:30 GMT
... Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover and manufacture products that will improve ...
Schering-Plough Schedules Conference Call and Webcast for 2008 Fourth Quarter and Full Year Earnings 6 Jan 2009 17:44 GMT
... full year on Tuesday, Feb. 3, 2009. At 8 a.m. (EST) on that day, Schering-Plough will conduct a conference call to review results for the 2008 fourth quarter and ...
Aveo Pharmaceuticals to Present at 27th Annual J.P. Morgan Healthcare Conference 6 Jan 2009 15:52 GMT
... targets (HGF, FGFR), as well as collaborations with Eli Lilly, Merck, OSI Pharmaceuticals and Schering-Plough. The company's lead product, AV-951, a potential best-in-class triple VEGF receptor inhibitor, is completing ...
Energy drink is most-produced drug 6 Jan 2009 15:30 GMT
... ulcer treatment made by Dong-A; Ultravist 300, a nonionic contrast agent produced by Bayer Schering Pharma; and Sanofi-Aventis�� Plavix blood thinner also made the top five most-produced drugs here ...
Anacor Pharmaceuticals raises $50M in equity financing 6 Jan 2009 15:30 GMT
... Tuesday it raised $50 million through a preferred stock financing with participation from GlaxoSmithKline, Schering Corp. and existing investors. The Palo Alto-based company said the investments from GSK and ...

Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals 6 Jan 2009 15:20 GMT
... growing market for testosterone replacement therapies. Indevus acquired U.S. rights to NEBIDO from Bayer Schering Pharma AG, Germany in July 2005. The Indevus octreotide implant is a proprietary formulation ...
Anacor Raises $50 Million in Equity Financing 6 Jan 2009 13:51 GMT
... announced that it has raised through a preferred stock financing with participation from GlaxoSmithKline, Schering Corporation and existing investors including Rho Capital Partners, Venrock Associates, Care Capital and Aberdare ...
GeneGo Renews Its Agreement With Bayer Schering Pharma AG for Another Three Years 6 Jan 2009 13:51 GMT
... GeneGo Renews Its Agreement With Bayer Schering Pharma AG for Another Three Years /PRNewswire/ -- GeneGo, Inc., a leading provider of ...
Schering-Plough: new infertility drug only partially addresses unmet need 6 Jan 2009 13:51 GMT
... Following the announcement in July 2008 of the successful completion of the Engage trial, Schering-Plough's corifollitropin alpha (Org-36286) has now been accepted for review by the European Medicine Agency. ...
Anacor Raises $50 Million in Equity Financing 6 Jan 2009 13:31 GMT
... in Equity Financing Anacor Raises $50 Million in Equity Financing - Investments from GlaxoSmithKline, Schering Corporation and Existing Investors - PALO ALTO, Calif., Jan. 6 /PRNewswire/ -- Anacor Pharmaceuticals ...
GeneGo Renews Its Agreement With Bayer Schering Pharma AG for Another Three Years 6 Jan 2009 12:30 GMT
... quality manually curated databases for systems biology and pathway analysis, today announced that Bayer Schering Pharma AG has renewed its MetaCore licenses for another three years. Bayer Schering Pharma ...
Biomagnetics (OTC BMGP) Releases Financing Details for Chinese Stem Cell / Biotech Division and Core Technology Development 6 Jan 2009 11:30 GMT
... established Western drug makers and biotech's Merck & Co. Wyeth, Eli Lilly & Co., Schering-Plough, Genentech, Bristol Meyers Squibb and many others that are ramping up investments in China, ...
XOMA Appoints Fred Kurland as Chief Financial Officer 6 Jan 2009 01:12 GMT
... developing its own products, XOMA develops products with premier pharmaceutical companies including Novartis AG, Schering-Plough Research Institute and Takeda Pharmaceutical Company Limited. XOMA has a fully integrated product development ...
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals 5 Jan 2009 22:13 GMT
... growing market for testosterone replacement therapies. Indevus acquired U.S. rights to NEBIDO from Bayer Schering Pharma AG, Germany in July 2005. The Indevus octreotide implant is a proprietary formulation ...
Letter to Digital Angel Stockholders from CEO Joseph J. Grillo 5 Jan 2009 21:30 GMT
... more specific to Digital Angel, such as the excess inventory of pet chips at Schering-Plough that we have been working through, or the top-line impact in dollar terms at ...

1 - 15 / 129 NEXT >>>

NOT SATISFIED WITH THIS SCHERING NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.

These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>